Response To mRNA COVID-19 Vaccination Similar Regardless Of Timing Following Cellular Therapy, Study Finds

Infectious Disease Advisor (7/3, McSwiggin) reported, “Humoral and cellular responses following COVID-19 mRNA vaccination were found to be similar between patients who received the vaccine fewer than 4 months vs 4 to 12 months after cellular therapy, according to study results published in Clinical Infectious Diseases.” In the study, “the percentage of autologous and allogeneic HCT recipients with positive antibody responses increased with vaccination and was similar at the end-of-study timepoint, irrespective of vaccination timing.”